TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair
TargetSterol regulatory element-binding protein 2(Homo sapiens (Human))
Asteroid Therapeutics
US Patent
Asteroid Therapeutics
US Patent
Affinity DataIC50: 125nMAssay Description:10,000 cells/well of the PathHunter U2OS SREBP-2 Nuclear Translocation Cell Line are plated in quadruplicate on 384 well plates in 20 μL of Assa...More data for this Ligand-Target Pair